Publicacións (222) Publicacións de Rafael López López

2024

  1. Biomarkers for Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Systematic Review

    Cancers, Vol. 16, Núm. 7

  2. Enhancing patient outcomes: Integrating electronic cardiology consultation in primary care for cancer patients

    European Journal of Clinical Investigation

  3. Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management

    Scientific Reports, Vol. 14, Núm. 1

  4. First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

    Breast Cancer Research and Treatment, Vol. 206, Núm. 2, pp. 317-328

  5. Genome-wide DNA methylation profiling in tongue squamous cell carcinoma

    Oral Diseases, Vol. 30, Núm. 2, pp. 259-271

  6. Indicators to evaluate quality of care in head and neck cancer in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 5, pp. 1089-1097

2023

  1. Agitación psicomotriz y conducta agresiva en urgencias pediátricas

    Revista de Psiquiatría Infanto-Juvenil, Vol. 40, Núm. 1, pp. 4-12

  2. Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials

    Clinical Colorectal Cancer, Vol. 22, Núm. 2, pp. 222-230

  3. Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial

    ESMO Open, Vol. 8, Núm. 4

  4. Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 3, pp. 1046-1055

  5. Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment

    Biomaterials Science, Vol. 11, Núm. 12, pp. 4210-4225

  6. Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer

    Frontiers in Cell and Developmental Biology, Vol. 11

  7. Erratum: Correction: Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer (Cancer research (2017) 77 21 (5846-5859))

    Cancer research

  8. Erratum: Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment (Biomaterials Science (2023) DOI: 10.1039/d2bm01456d

    Biomaterials Science

  9. Extracellular Vesicles’ Genetic Cargo as Noninvasive Biomarkers in Cancer: A Pilot Study Using ExoGAG Technology

    Biomedicines, Vol. 11, Núm. 2

  10. Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers

    Frontiers in Immunology, Vol. 14

  11. MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles

    iScience, Vol. 26, Núm. 3

  12. Modelling metastasis in zebrafish unveils regulatory interactions of cancer-associated fibroblasts with circulating tumour cells

    Frontiers in Cell and Developmental Biology, Vol. 11

  13. Noninvasive detection of microsatellite instability in patients with endometrial cancer

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217

  14. Occupation as a risk factor of small cell lung cancer

    Scientific Reports, Vol. 13, Núm. 1